Cancer Diagnostic Innovations

Agenda

Networking: 4 - 4:30 p.m.
Panel: 4:30 - 5:15 p.m.
Networking: 5:15 - 6:30 p.m.

Cancer diagnostics have made enormous strides in the past decade. These developments include the use of liquid biopsies, artificial intelligence, and biomarkers to improve both diagnosis and treatment. Cancer diagnoses can now be made long before patients exhibit symptoms, potentially saving many more lives. Much of this work is happening here in Baltimore! Please join us as we discuss development and commercialization efforts with local companies advancing the latest diagnostic innovations.

Moderator
Christina DeMur
Director of Technology Development
Johns Hopkins Technology Ventures

Panelists
Daniel Lunz
CEO and Co-founder
Previse (formerly Capsulomics)

Victor Velculescu, MD, PhD
Founder and CEO
Delfi Diagnostics

Professor of Oncology
Johns Hopkins University School of Medicine

Daniel Edelstein
CEO and Co-founder
Haystack Oncology

Sponsored by